Cheapest Wegovy UK Price - From £69.00 Monthly

Our Pricing

Buy Wegovy Online UK: Monthly Costs From £69.00

Published on: June 03, 2026

When you buy Wegovy online UK monthly cost plans start from £79.00 at Cured Pharmacy, making this MHRA-licensed semaglutide treatment accessible with transparent upfront pricing. Our UK-registered clinical team provides free online consultations under three minutes, with all genuine medicines dispensed by superintendent pharmacist Tarun Kumar (GPhC 2233073).

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 to regulate appetite and food intake [1]. By activating GLP-1 receptors in the brain, Wegovy helps reduce hunger signals whilst slowing gastric emptying, creating a sustained feeling of fullness after smaller meals.

In the landmark STEP 1 clinical trial, adults using Wegovy alongside lifestyle interventions achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. The STEP 3 trial demonstrated even greater results, with participants losing an average 16.0% of their initial body weight when combining Wegovy with intensive behavioural therapy [2].

Wegovy is licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes or hypertension [3]. Treatment requires ongoing clinical supervision and is most effective when combined with a reduced-calorie diet and increased physical activity.

Wegovy Monthly Cost Breakdown UK

At Cured Pharmacy, Wegovy pricing starts from £79.00 per month with transparent costs shown before your consultation begins. Your monthly cost depends on your prescribed dose, which your UK prescriber determines based on your individual response and tolerability during the dose escalation schedule.

The Wegovy dosing schedule follows a gradual escalation protocol over 16-20 weeks to minimise gastrointestinal side effects. You'll typically start at 0.25mg weekly for four weeks, increasing every four weeks through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly [3]. Each dose strength is priced according to the pen configuration required for that treatment phase.

Unlike some providers who advertise low entry prices but add hidden consultation fees or subscription charges, Cured Pharmacy guarantees the lowest prices in the UK with no surprise costs. Your prescription includes the medication, clinical assessment by a UK-registered prescriber, and discreet next-day delivery to your home or preferred address.

What's Included in Your Monthly Wegovy Cost

Every Wegovy prescription from Cured Pharmacy includes a comprehensive clinical consultation with a UK prescriber, genuine MHRA-licensed medication dispensed by our registered pharmacy team, and fully tracked delivery in discreet packaging. There are no membership fees, no automatic renewals without your consent, and no obligation to continue treatment beyond your current prescription period.

Wegovy vs Alternative Weight Loss Treatments

Semaglutide-based Wegovy represents one of several prescription weight loss options available through UK pharmacies, each with distinct mechanisms and clinical profiles. Understanding the differences helps you and your prescriber select the most appropriate treatment for your circumstances.

Saxenda contains liraglutide, an earlier GLP-1 receptor agonist requiring daily injections rather than Wegovy's once-weekly schedule. Clinical trials showed Saxenda users achieved an average 8.0% body weight reduction over 56 weeks, lower than Wegovy's 14.9% average but still clinically significant for many patients [4]. The daily injection schedule may suit individuals who prefer more frequent dosing control.

Orlistat works through a completely different mechanism as a lipase inhibitor that reduces dietary fat absorption in the intestines. Available in prescription-strength 120mg capsules, orlistat produced an average 2.9kg greater weight loss than placebo over 12 months in meta-analysis [5]. It's typically considered when injectable treatments aren't suitable or preferred by the patient.

Choosing Between Wegovy and Other Options

Your UK prescriber will assess your medical history, current medications, weight loss goals, and personal preferences during your consultation. Factors influencing treatment selection include your BMI, presence of type 2 diabetes or other comorbidities, tolerance for injection-based treatments, and previous weight loss attempts. All prescription weight loss medications require clinical assessment and ongoing monitoring for safety and efficacy.

Buy Wegovy Online UK: The Clinical Assessment Process

Wegovy is a prescription-only medicine in the UK, meaning you cannot legally purchase it without a valid prescription from a UK-registered prescriber. At Cured Pharmacy, our streamlined online consultation takes under three minutes whilst maintaining full clinical rigour and regulatory compliance with GPhC and MHRA standards.

During your assessment, you'll answer questions about your current weight and height, medical history including cardiovascular conditions and previous weight loss attempts, current medications that might interact with semaglutide, and any history of thyroid disease or pancreatitis. Our UK prescribers review every consultation individually—there are no automated approvals or algorithmic decisions about your care.

If Wegovy is deemed clinically appropriate for you, your prescription is sent electronically to our dispensary where superintendent pharmacist Tarun Kumar and his team prepare your medication. We dispatch via tracked courier with discreet packaging that contains no external pharmacy branding or treatment information, arriving at your chosen address the next working day in most UK postcodes.

Wegovy Side Effects and Safety Considerations

The most common side effects of Wegovy are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal pain [3]. In the STEP trials, these effects were generally mild to moderate and decreased over time as patients adjusted to treatment. The gradual dose escalation schedule specifically aims to minimise these initial reactions.

More serious but rare risks include potential thyroid C-cell tumours (observed in rodent studies but not conclusively demonstrated in humans), acute pancreatitis, gallbladder disease, and hypoglycaemia particularly in patients taking other glucose-lowering medications [3]. Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Your prescriber will discuss your individual risk profile during consultation and provide guidance on recognising concerning symptoms that require immediate medical attention. Regular monitoring appointments—whether through our pharmacy or your NHS GP—are essential for safe long-term weight management with Wegovy.

Managing Common Side Effects

Most patients find gastrointestinal side effects improve significantly after the first few weeks on each new dose level. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and not lying down immediately after eating can all help reduce nausea and discomfort. If side effects remain troublesome, your prescriber may recommend staying at your current dose longer before escalating, or in some cases reducing to a previously tolerated dose.

Maximising Weight Loss Results with Wegovy

Wegovy is licensed as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone treatment [3]. Clinical trial participants who achieved the greatest weight loss combined their medication with structured lifestyle interventions including nutritional counselling and regular exercise programmes.

NICE guidance recommends setting realistic initial weight loss targets of 5-10% of starting body weight, with ongoing treatment continuation dependent on achieving at least 5% weight loss after 6 months [6]. Patients who don't reach this threshold should discontinue Wegovy, as continued use is unlikely to produce clinically meaningful benefits and exposes them to unnecessary side effects and costs.

Sustainable weight management requires addressing behavioural patterns, emotional eating triggers, sleep quality, and stress management alongside medication. Many patients benefit from keeping a food diary, planning meals in advance, finding enjoyable forms of physical activity, and building a support network of family, friends, or weight loss groups. Your prescriber can provide additional resources and may refer you to specialist weight management services if appropriate.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., ... & Rubino, D. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. (2007). Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ, 335(7631), 1194–1199. https://doi.org/10.1136/bmj.39385.413113.25 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.